SCHEMBL3175636

SCHEMBL3175636

[O]c1ccc(Cc2c(O)c3ccccc3oc2=O)cc1

nearest known ligand 0.81

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 6/20 0.81
VKORC1 Q9BQB6 8/20 0.77
ALDH1A1 P00352 2/20 0.74
LMNA P02545 2/20 0.74
TP53 P04637 2/20 0.74
TSHR P16473 2/20 0.74
MAPK1 P28482 2/20 0.74
MEN1 O00255 1/20 0.74
ABCB11 O95342 1/20 0.74
CYP1A2 P05177 1/20 0.74
CYP3A4 P08684 1/20 0.74
CYP2C9 P11712 1/20 0.74
CYP2C19 P33261 1/20 0.74
KMT2A Q03164 1/20 0.74
PDE4D Q08499 1/20 0.74
PCSK7 Q16549 1/20 0.74
GPR35 Q9HC97 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1648127 0.90 NQO1 (0.83) NQO1VKORC1ALDH1A1LMNATP53
SCHEMBL1648186 0.89 NQO1 (1.00) NQO1VKORC1ALDH1A1LMNATP53
Dicumarol SCHEMBL7454901 0.86 NQO1 (1.00) NQO1VKORC1ALDH1A1LMNATP53
Dicumarol SCHEMBL33891 0.86 NQO1 (1.00) NQO1VKORC1ALDH1A1LMNATP53
Dicumarol SCHEMBL29703314 0.86 NQO1 (1.00) NQO1VKORC1ALDH1A1LMNATP53
SCHEMBL29655586 0.85 NQO1 (0.79) NQO1VKORC1ALDH1A1LMNATP53
SCHEMBL1649892 0.85 NQO1 (0.79) NQO1VKORC1ALDH1A1LMNATP53
SCHEMBL1648171 0.85 NQO1 (0.79) NQO1VKORC1ALDH1A1LMNATP53
Dicumarol SCHEMBL17927706 0.84 NQO1 (0.96) NQO1VKORC1ALDH1A1LMNATP53
SCHEMBL8333624 0.83 VKORC1 (0.92) NQO1VKORC1ALDH1A1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161261-B1 Materials and methods for treating coagulation disorders ARMETHEON INC (US) 2013-08-28 EP disclosed
EP-2161261-A1 Materials and methods for treating coagulation disorders Aryx Therapeutics (US) 2010-03-10 EP disclosed
EP-1735296-B1 MATERIALS AND METHODS FOR TREATING COAGULATION DISORDERS ARYX THERAPEUTICS (US) 2009-12-09 EP disclosed